Skip to results
Modify your search
NARROW
1-4 of 4
Authors: Giovanni Parmigiani
Sort by
Journal Article
EDITOR'S CHOICE
The clinical trials landscape for glioblastoma: is it adequate to develop new treatments? Free
Alyssa M Vanderbeek and others
Neuro-Oncology, Volume 20, Issue 8, August 2018, Pages 1034–1043, https://doi.org/10.1093/neuonc/noy027
Published: 05 April 2018
Journal Article
EDITOR'S CHOICE
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma Free
Shyam K. Tanguturi and others
Neuro-Oncology, Volume 19, Issue 7, July 2017, Pages 908–917, https://doi.org/10.1093/neuonc/now312
Published: 20 February 2017
Journal Article
Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials
Get access
Lorenzo Trippa and others
Neuro-Oncology, Volume 17, Issue 8, August 2015, Pages 1106–1113, https://doi.org/10.1093/neuonc/nou345
Published: 07 January 2015
Journal Article
Biomarker-based adaptive trials for patients with glioblastoma—lessons from I-SPY 2
Get access
Brian M. Alexander and others
Neuro-Oncology, Volume 15, Issue 8, August 2013, Pages 972–978, https://doi.org/10.1093/neuonc/not088
Published: 01 August 2013
Advertisement
Advertisement